Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019214 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: MART-1 antigen
BIOLOGICAL: aldesleukin
BIOLOGICAL: gp100 antigen

Sponsor

National Cancer Institute (NCI)